Revolutionization in Cancer Therapeutics via Targeting Major Immune Checkpoints PD-1, PD-L1 and CTLA-4

Numerous research reports have witnessed dramatic advancements in cancer therapeutic approaches through immunotherapy. Blocking immunological checkpoint pathways (mechanisms employed by malignant cells to disguise themselves as normal human body components) has emerged as a viable strategy for devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandey, Pratibha, Khan, Fahad, Qari, Huda A., Upadhyay, Tarun Kumar, Alkhateeb, Abdulhameed F., Oves, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952773/
https://www.ncbi.nlm.nih.gov/pubmed/35337133
http://dx.doi.org/10.3390/ph15030335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952773/
https://www.ncbi.nlm.nih.gov/pubmed/35337133
http://dx.doi.org/10.3390/ph15030335

Ejemplares similares